• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply: Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?回复：双主动脉瓣狭窄与转甲状腺素蛋白型心脏淀粉样变：我们有足够的证据吗？
JACC CardioOncol. 2022 Mar 15;4(1):144-145. doi: 10.1016/j.jaccao.2022.02.005. eCollection 2022 Mar.
2
Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.转甲状腺素蛋白心脏淀粉样变性与主动脉瓣狭窄：关联及治疗意义
Curr Cardiol Rev. 2020;16(3):221-230. doi: 10.2174/1573403X15666190722154152.
3
Subthreshold Aortic Valve Calcium Scores in Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis.重度主动脉瓣狭窄和转甲状腺素蛋白心脏淀粉样变中的亚阈值主动脉瓣钙评分
JACC Case Rep. 2020 Nov 18;2(14):2205-2209. doi: 10.1016/j.jaccas.2020.10.002.
4
[Wild-type transthyretin-related cardiac amyloidosis and degenerative aortic stenosis: Two inter-related pathologies in the elderly].[野生型转甲状腺素蛋白相关心脏淀粉样变性与退行性主动脉瓣狭窄：老年人中的两种相关病理情况]
Rev Esp Geriatr Gerontol. 2017 May-Jun;52(3):167-170. doi: 10.1016/j.regg.2016.05.002. Epub 2016 Jun 10.
5
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.心脏转甲状腺素蛋白淀粉样变合并主动脉瓣狭窄：患病率、诊断挑战及临床意义。
Hellenic J Cardiol. 2020 Mar-Apr;61(2):92-98. doi: 10.1016/j.hjc.2019.10.004. Epub 2019 Nov 15.
6
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.严重钙化性主动脉瓣狭窄中的隐匿性转甲状腺素蛋白心脏淀粉样变：接受外科主动脉瓣置换术患者的患病率及预后
Circ Cardiovasc Imaging. 2016 Aug;9(8). doi: 10.1161/CIRCIMAGING.116.005066.
7
Antegrade Balloon Aortic Valvuloplasty for the Highly Frail Patient of Severe Aortic Stenosis Complicated with Transthyretin-type Cardiac Amyloidosis.顺行球囊主动脉瓣成形术治疗合并转甲状腺素蛋白型心脏淀粉样变性的重度主动脉瓣狭窄高龄体弱患者
Intern Med. 2020 Apr 15;59(8):1053-1057. doi: 10.2169/internalmedicine.3870-19. Epub 2019 Dec 26.
8
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.揭示并存严重主动脉瓣狭窄和转甲状腺素蛋白心脏淀粉样变性的结果。
Eur J Heart Fail. 2021 Feb;23(2):250-258. doi: 10.1002/ejhf.1974. Epub 2020 Sep 8.
9
Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.主动脉瓣狭窄与心脏淀粉样变性：美国心脏病学会评论专题周报
J Am Coll Cardiol. 2019 Nov 26;74(21):2638-2651. doi: 10.1016/j.jacc.2019.09.056.
10
Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?主动脉瓣狭窄、经导管主动脉瓣置换术与转甲状腺素蛋白心脏淀粉样变性：我们是否正在逐步解开这一难题？
Eur J Heart Fail. 2021 Feb;23(2):259-263. doi: 10.1002/ejhf.2057. Epub 2020 Nov 25.

本文引用的文献

1
Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.同时患有心脏淀粉样变性和主动脉瓣狭窄的患病率和结局：系统评价和荟萃分析。
Hellenic J Cardiol. 2022 Mar-Apr;64:67-76. doi: 10.1016/j.hjc.2021.11.001. Epub 2021 Nov 29.
2
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.印度老年人群中伴发甲状腺素运载蛋白淀粉样变与严重主动脉瓣狭窄：一项初步研究
JACC CardioOncol. 2021 Oct 19;3(4):565-576. doi: 10.1016/j.jaccao.2021.08.008. eCollection 2021 Oct.
3
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications.主动脉瓣狭窄中的转甲状腺素蛋白淀粉样变性：临床及治疗意义
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E128-E132. doi: 10.1093/eurheartj/suab107. eCollection 2021 Oct.
4
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.心脏转甲状腺素蛋白淀粉样变性的自然病史、生活质量和结局。
Circulation. 2019 Jul 2;140(1):16-26. doi: 10.1161/CIRCULATIONAHA.118.038169. Epub 2019 May 21.
5
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.系统性心脏淀粉样变：3种主要类型的疾病特征与临床病程
Circulation. 2009 Sep 29;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334. Epub 2009 Sep 14.

Reply: Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?

作者信息

Singal Aayush Kumar, Singh Avinainder, Bansal Raghav, Mishra Sundeep

出版信息

JACC CardioOncol. 2022 Mar 15;4(1):144-145. doi: 10.1016/j.jaccao.2022.02.005. eCollection 2022 Mar.

DOI:10.1016/j.jaccao.2022.02.005
PMID:35492829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9040100/
Abstract
摘要